<DOC>
	<DOCNO>NCT02782663</DOCNO>
	<brief_summary>This open-label extension ( OLE ) study design evaluate long-term efficacy , safety , tolerability ABT-494 .</brief_summary>
	<brief_title>A Study Evaluate Long-Term Efficacy , Safety , Tolerability Repeated Administration ABT-494 Subjects With Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Participant must complete Study M13740 Week 52 . If female , participant must postmenopausal , surgically sterile use birth control method . For reason participant consider investigator unsuitable candidate Female participant positive pregnancy test Baseline consider become pregnant study . Participant compliance prior concomitant medication requirement procedures throughout Study M13740 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Crohn 's Disease</keyword>
	<keyword>Tolerability</keyword>
	<keyword>ABT-494</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Safety</keyword>
</DOC>